Precision Business Insights
Portfolio

 

Research Reports

Europe Poultry Vaccines Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2023

Europe Poultry Vaccines Market: By Vaccine Type (Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines), By Formulation (Dry Form (Duct) Vaccines, Liquid Vaccines, Freeze Dried Vaccines), By Application (Marek’s Disease, Newcastle Disease, Infectious Bursal Disease, Infectious Bronchitis, Others), and Geography – Europe Poultry Vaccines Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

 

Market Dynamics: Europe Poultry Vaccines Market

 

Vaccines are biological preparations that provide acquired immunity to particular disease in human beings or animals. Poultry vaccines are used to prevent or cure the various diseases in poultry such as Marek’s disease, Newcastle disease, and infectious diseases among others. Increase in the demand for healthy meat and poultry products, rise in R&D activities for the innovation and adoption of newer poultry vaccines, increase in the prevalence of avian influenza and Newcastle diseases, and growing awareness about the poultry diseases among veterinary professionals are expected to boost the Europe poultry vaccines market over the forecast period. However, stringent regulatory guidelines for vaccine approvals and high cost for R&D activities may restrain the growth of poultry vaccines market in forthcoming years.

 

Market Scope: Europe Poultry Vaccines Market

Europe poultry vaccines market is segmented on the basis of vaccine type, formulation, application, and country

Based on the vaccine type, the market is segmented into the following:

  • Inactivated Vaccines
  • Live Attenuated Vaccines
  • Recombinant Vaccines

Based on the formulation, the market is segmented into the following:

  • Dry Form (Duct) Vaccines
  • Liquid Vaccines
  • Freeze Dried Vaccines

Based on the application, the market is segmented into the following:

  • Marek’s Disease
  • Newcastle Disease
  • Infectious Bursal Disease
  • Infectious Bronchitis
  • Others

Based on the country, the market is segmented into the following:

  • Germany
  • France
  • K
  • Italy
  • Spain
  • Russia
  • Poland
  • Rest of Europe

 

Country Analysis:  Poultry Vaccines Market

Geographically, Europe poultry vaccines market is segmented into Germany, France, U.K, Italy Spain, Russia, Poland, and Rest of Europe. Germany poultry vaccines market is expected to exhibit significant growth due to rise in population demanding for healthy meat, increase in R&D activities for the innovation of newer vaccines, and rise in prevalence of infectious diseases such as bird flu (according to Germany Agriculture Ministry, about 776,000 poultry are culled between November 2016 to February 2017 due to bird flu). France poultry vaccines market has a significant share in Europe market, which is attributed to escalation in avian influenza outbreak in poultry, acquisitions and mergings between the companies, and launching of newer vaccines by France companies. U.K. poultry vaccines market has a lucrative growth owing to government support for the poultry production, funding from the government organizations for the development of poultry vaccines, and increase in animal welfare expenditure.

 

Competition Assessment: Europe Poultry Vaccines Market

Some of the players in the Europe poultry vaccines market include:

  • Zoetis (Pfizer, Inc.) (U.S.)
  • Merck & Co. Inc. (U.S)
  • Boehringer Ingelheim Vetmedica (Germany)
  • Elanco (U.S.)
  • Bayer Animal Health (Germany)
  • Ceva Sante Animale (France)
  • Zydus AHL (India)
  • C Romvac Company S.A. (Romania)
  • AniCon Labor GmbH (Germany)

 

Notable Market Developments: Europe Poultry Vaccines Market

  • In September 2017, Merck Animal Health launched Innovax-ND-IBD poultry live vaccine used to prevent the Newcastle disease, Marek’s disease, and infectious bursal disease

 

Key Features of the Report:

  • The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies and regulatory framework
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
  • Zoetis (Pfizer, Inc.) (U.S.)
  • Merck & Co. Inc. (U.S)
  • Boehringer Ingelheim Vetmedica (Germany)
  • Elanco (U.S.)
  • Bayer Animal Health (Germany)
  • Ceva Sante Animale (France)
  • Zydus AHL (India)
  • C Romvac Company S.A. (Romania)
  • AniCon Labor GmbH (Germany)

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

 

$ 2,000.00$ 6,900.00
Region Europe
Clear selection

Select License Type

Databank Europe $ 2,000.00
spinner
Single User Europe $ 3,100.00
spinner
Multiple User Europe $ 4,600.00
spinner
Corporate UserEurope $ 6,900.00
spinner
buy now spinner
FacebookTwitterLinkedinEmail

Our Clients

Testimonials